Article Cited by others

INVITED REVIEW

Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations

Morgentaler Abraham, Conners William P

Year : 2015| Volume: 17| Issue : 2 | Page no: 206-211

   This article has been cited by
 
1 Intermittent Hormone Therapy Models Analysis and Bayesian Model Comparison for Prostate Cancer
S. Pasetto, H. Enderling, R. A. Gatenby, R. Brady-Nicholls
Bulletin of Mathematical Biology. 2022; 84(1)
[Pubmed]  [Google Scholar] [DOI]
2 Low testosterone and high cholesterol levels in relation to all-cause, cardiovascular disease, and cancer mortality in White, Black, and Hispanic men: NHANES 1988–2015
David S. Lopez, Wei-Chen Lee, Carlos Orellana Garcia, Paige Birkelbach Downer, Shaden Taha, Alejandro Villasante-Tezanos, Konstantinos K. Tsilidis, Kristen Peek, Markides Kyriakos, Steven Canfield
Hormones. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Safety of androgen therapy in men with prostate cancer
Mr Prabhakar Rajan, Tharu Tharakan, Runzhi Chen
Best Practice & Research Clinical Endocrinology & Metabolism. 2022; : 101628
[Pubmed]  [Google Scholar] [DOI]
4 Testosterone therapy in prostate cancer: is it still a controversy?
Alex S. Bart, Alexander Van Hoof, Ryan Badre-Hume, Joshua Selvarajah, Kristian Robillard, David M. Albala
Current Opinion in Urology. 2022; Publish Ah
[Pubmed]  [Google Scholar] [DOI]
5 Testosterone Therapy After Prostate Cancer Treatment: A Review of Literature
Caleb Natale,Carmen Carlos,Jennifer Hong,Mohit Khera,Neil Baum,Omer A. Raheem
Sexual Medicine Reviews. 2021;
[Pubmed]  [Google Scholar] [DOI]
6 Male hypogonadism: a review
Marco Marcelli,Sanjay Navin Mediwala
Journal of Investigative Medicine. 2020; 68(2): 335
[Pubmed]  [Google Scholar] [DOI]
7 Oncological safety and functional outcomes of testosterone replacement therapy in symptomatic adult-onset hypogonadal prostate cancer patients following robot-assisted radical prostatectomy
Hanna Shahine,Marc Zanaty,Ahmed S. Zakaria,David-Dan Nguyen,Felix Couture,Iman Sadri,Russel Schwartz,Adel Arezki,Dean Elterman,Assaad El-Hakim,Kevin C. Zorn
World Journal of Urology. 2020;
[Pubmed]  [Google Scholar] [DOI]
8 Testosterone therapy for high-risk prostate cancer survivors: a systematic review and meta-analysis
Fiona Teeling,Mr Nicholas Raison,Mr Majed Shabbir,Mr Tet Yap,Professor Prokar Dasgupta,Mr Kamran Ahmed
Urology. 2018;
[Pubmed]  [Google Scholar] [DOI]
9 Quality of life and sexual health in men with prostate cancer undergoing radical prostatectomy
Angela M. E. P. Naccarato,Sophia Consuelo Souto,Wagner E. Matheus,Ubirajara Ferreira,Fernandes Denardi
The Aging Male. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
10 Sexual Rehabilitation After Treatment For Prostate Cancer—Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015)
Andrea Salonia,Ganesh Adaikan,Jacques Buvat,Serge Carrier,Amr El-Meliegy,Kostas Hatzimouratidis,Andrew McCullough,Abraham Morgentaler,Luiz Otavio Torres,Mohit Khera
The Journal of Sexual Medicine. 2017; 14(3): 297
[Pubmed]  [Google Scholar] [DOI]
11 Testosterone Therapy and Prostate Cancer
Emily Davidson,Abraham Morgentaler
Urologic Clinics of North America. 2016; 43(2): 209
[Pubmed]  [Google Scholar] [DOI]
12 Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk
Jason E. Michaud,Kevin L. Billups,Alan W. Partin
Therapeutic Advances in Urology. 2015; 7(6): 378
[Pubmed]  [Google Scholar] [DOI]
13 Controversies in testosterone supplementation therapy
Mohit Khera
Asian Journal of Andrology. 2015; 17(2): 175
[Pubmed]  [Google Scholar] [DOI]

 

Read this article